pentobarbital will reduce the level or effect of bedaquiline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Steer clear of coadministration of bedaquiline with potent CYP3A4 inducers due to opportunity for lowered therapeutic influencepentobarbital will minimize the extent or impact of cilostazol b